Test Price
2,800 AED✅ Home Collection Available
ATXN7 Gene (Spinocerebellar Ataxia Type 7) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ATXN7 (الرنح النخاعي المخيخي من النوع 7) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary — ملخص تنفيذي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed neurologists.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
يقدم هذا الاختبار الجيني المتطور تحليلاً شاملاً لجين ATXN7 باستخدام تقنية تسلسل الجيل التالي (NGS) لتشخيص الرنح النخاعي المخيخي من النوع 7 بدقة تبلغ 99.9%، مع خدمة سحب منزلي معتمدة وفق معايير الجودة العالمية، ودعم استشاري بعد النتيجة من أطباء أعصاب مرخصين من هيئة الصحة بدبي.
Overview
The ATXN7 genetic test uses Genetic Test provides definitive molecular evidence for patients with progressive ataxia, visual loss, and a family history of neurological disorders.
| Feature | Our Test (NGS Panel) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Single-nucleotide resolution with complete CAG repeat sizing | Limited to targeted region; may miss mosaicism |
| Method | NGS + bioinformatic CAG repeat expansion analysis | Sanger sequencing with fragment analysis |
| Speed | 3–4 weeks with clinical report | 4–6 weeks, often requires repeat testing |
Physician Insight & Safety Protocol
“As a neurologist, I emphasize that a positive ATXN7 test confirms the genetic aetiology of ataxia but must be correlated with clinical findings and family history; a negative result does not exclude other hereditary ataxias. Please continue all prescribed medications unless your doctor advises otherwise, and do not interpret this test in isolation. Genetic counselling is mandatory before and after sampling.”
— Dr. Prabhakar Reddy, DHA License: 61713011
⚠ Medication & Safety Warning
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation of antiepileptics, antidepressants, or other neurologically active drugs can precipitate severe withdrawal symptoms or disease exacerbation.
Exclusion Criteria & Emergency Red Flags
- Inappropriate sample type (e.g., saliva, buccal swab without prior approval).
- Minors without court-ordered consent or verified parental/guardian authorization (UAE CDS Law 2026).
- Individuals unable to provide informed consent or without a pre-test genetic counselling session.
- ER Red Flags: Sudden loss of vision, severe dysphagia, acute respiratory distress, or loss of consciousness within weeks of onset — seek immediate emergency care; these may indicate rapid disease progression unrelated to test status.
Patient FAQ & Clinical Guidance
Q: What is the ATXN7 genetic test and how is it performed?
The ATXN7 genetic test is a Next Generation Sequencing analysis that detects CAG repeat expansions in the ATXN7 gene to diagnose Spinocerebellar Ataxia Type 7. A small blood sample (or extracted DNA) is collected via cold-chain home phlebotomy, and NGS technology counts the number of CAG repeats with high accuracy. Results are interpreted alongside a genetic counsellor and your neurologist to confirm autosomal dominant inheritance and guide prognosis.
س: ما هي استخدامات تحليل جين ATXN7 وهل هو مؤلم؟
تحليل جين ATXN7 هو اختبار دم بسيط غير مؤلم يستخدم تقنية التسلسل الجيني المتقدم لتشخيص الرنح النخاعي المخيخي من النوع 7 بدقة عالية. يتم سحب عينة الدم في المنزل بواسطة ممرض متخصص خلال دقائق، ثم تُحلل في مختبرنا المعتمد دوليًا للكشف عن تمددات متكررات CAG المسببة للمرض. النتيجة تساعد الأطباء في تأكيد التشخيص الوراثي وتقديم الاستشارة الوراثية للعائلة.
Q: How do I pay or claim insurance for this test?
We offer direct insurance billing verification via WhatsApp at +971 54 548 8731 before sample collection to confirm coverage. If paying out-of-pocket, the cost is 2800 AED, payable online via secure link or upon phlebotomist arrival. Most UAE insurers cover genetic testing for neurological disorders when medically indicated; we assist with pre-authorization forms and provide an itemized receipt for reimbursement.
UAE Regulatory Compliance: This testing service adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), UAE Child Data Sovereignty (CDS) Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). All data processing meets ISO 9001:2015 standards (Cert: INT/EGQ/2509DA/3139).
Clinical Disclaimer: results must be interpreted by a qualified neurologist. This information does not replace professional medical advice.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians